GOLDMAN SACHS GROUP INC - 30 Sep 2025 SCHEDULE 13G Report for INTELLIA THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (NTLA)

Filing Manager
GOLDMAN SACHS GROUP INC
Reporting Manager
THE GOLDMAN SACHS GROUP, INC.
Security
INTELLIA THERAPEUTICS, INC. Common Stock, par value $0.0001 per share
Symbol
NTLA
Shares outstanding
107,809,066 shares
Disclosed Ownership
5,498,262 shares
Ownership
5.1%
Form type
SCHEDULE 13G
Filing time
12 Nov 2025, 15:55:19 UTC
Date of event
30 Sep 2025
Next filing
12 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"GOLDMAN SACHS GROUP INC disclosed 5.1% ownership in INTELLIA THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (NTLA) on 30 Sep 2025."

Quick Takeaways

  • GOLDMAN SACHS GROUP INC filed SCHEDULE 13G for INTELLIA THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (NTLA).
  • Disclosed ownership: 5.1%.
  • Date of event: 30 Sep 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 12 Nov 2025, 15:55.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
THE GOLDMAN SACHS GROUP, INC. 5.1% 5,498,262 0 5,497,802 Name: Sam Prashanth Attorney-in-fact
GOLDMAN SACHS & CO. LLC 5.1% 5,498,262 0 5,497,802 Name: Sam Prashanth Attorney-in-fact

Sponsored